Castle Creek Biosciences

Cell and Gene Therapy Company

Exton, United States · $167.8M raised

Business Model
B2B
Total Funding
$167.8M
Last Round
$112.8M Series DMay 2022
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 4 investors for this company. The full record is or through the API.

About

Castle Creek Biosciences is a late-stage cell and gene therapy company developing re-dosable gene therapies for severe genetic skin diseases. Its lead program, D-Fi, is in a registrational Phase 3 trial for dystrophic epidermolysis bullosa (DEB). A portfolio company of Paragon Biosciences, it is headquartered in Exton, Pennsylvania.

Summary

Castle Creek Biosciences is a Biotech company based in Exton, United States. It has raised $167.8M in total across 4 rounds, most recently a $112.8M Series D round in May 2022. Investors include Paragon Biosciences, Ligand Pharmaceuticals and Valor Equity Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Debt FinancingDebt FinancingFeb 2025
$75.0M

Sign up to see all 5 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Castle Creek Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/castle-creek-biosciences"><img src="https://indexed.vc/api/badge/company/castle-creek-biosciences" alt="Castle Creek Biosciences on Indexed.vc" width="260" height="76" /></a>